NUMERAL LIMITED - Numeral Opens 100% Subsidiary in South Africa - Numeral Biotechnologies (Pty) Ltd

Numeral Opens 100% Subsidiary in South Africa - Numeral Biotechnologies (Pty) Ltd

NUMERAL LTD
(formerly Go Life International Ltd)
(Incorporated in the Republic of Mauritius)
(Registration number: 098177 C1/GBL)
Primary Listing SEM share code: GOLI.N0000
Secondary Listing JSE share code: XII
ISIN: MU0330N00004
("the Company" or "Numeral")

NUMERAL OPENS 100% SUBSIDIARY IN SOUTH AFRICA –
NUMERAL BIOTECHNOLOGIES PROPRIETARY LIMITED ("NUMERAL BIOTECH")

Shareholders are advised that the Company has opened Numeral Biotech in South
Africa, as a 100% owned subsidiary. Biotechnology remains a key focus of the Group
and the Board is actively pursuing acquisitions in this sector.

This communiqué is issued pursuant to SEM Listing Rules 11.3, 12.14 and 12.20 and
section 88 of the Securities Act of Mauritius 2005 as well as the JSE Listings
Requirements. The Board accepts full responsibility for the accuracy of the
information contained in these Financial Statements.

Numeral has its primary listing on the SEM and a secondary listing on the Alternative
Exchange of the JSE.

For and on behalf of the board
Mauritius
2 October 2024

Executive Directors:                                         Non-Executive Directors:
Dave van Niekerk                                              Mohamed Yusuf Sooklall
Neville Graham                                                 Dr Aansa Devi Bedacee

JSE Sponsor:                                          Management Company and Company
AcaciaCap Advisors Proprietary Limited                                     Secretary:
                                                     LTS Management Services Limited

Date: 02-10-2024 12:45:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.